文献速递免疫规划

腹腔注射含TLR3激动剂的阳离子脂质体招募I型经典树突状细胞并启动局部CD8+ T细胞应答

Intraperitoneal administration of cationic liposomes containing a TLR3 agonist recruits type I conventional dendritic cells and primes a local CD8+ T cell response.
PubMed 文献 · Vaccine · 2025-11-27

该研究在小鼠中探究CAF®09b佐剂腹腔注射后的生物分布与免疫机制,发现其与内脏脂肪组织结合并在腹腔形成疫苗储库,招募BATF3依赖的cDC1并早期启动腹腔局部CD8+ T细胞应答,且该应答对FTY720处理 resistant。

要点

  • 腹腔注射CAF09b与内脏脂肪组织结合并在腹腔形成疫苗储库。
  • CAF09b招募BATF3依赖的迁移表型cDC1(CD11c+XCR1+CD103+)。
  • CAF09b诱导的CD8+ T细胞应答需要BATF3依赖的cDC1细胞。

核心结论

  • 佐剂可促进cDC1招募至腹腔,这可能有助于腹腔给药激发CD8+ T细胞应答的有效性。
  • CAF09b诱导的CD8+ T细胞应答需要BATF3依赖的cDC1细胞。

研究设计与样本

  • 在小鼠中开展的研究,探究CAF09b佐剂的生物分布及腹腔局部先天免疫细胞招募和CD8+ T细胞应答。

主要发现

  • 腹腔注射CAF09b与内脏脂肪组织结合并在腹腔形成疫苗储库。
  • 招募BATF3依赖的经典I型树突状细胞(cDC1),呈现迁移表型(CD11c+XCR1+CD103+)。
  • 基因本体分析显示与内脏脂肪组织树突状细胞相似。
  • 腹腔注射CAF09b早期启动腹腔局部CD8+ T细胞,且该应答对FTY720处理 resistant。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Therapeutic vaccines capable of eliciting CD8 T cell responses are a promising approach in cancer, but the magnitude of immune responses to peptide-based vaccine technologies has so far been modest in humans. The cationic liposome adjuvant CAF®09b has recently shown promising results in clinical trials, where it is administered intraperitoneally (i.p.), as preclinical studies demonstrated superior CD8 T cell responses when using this route compared to subcutaneous delivery. METHODS: Exploring the mechanism of CAF09b in mice we investigated biodistribution of the adjuvant and associated antigen in murine studies. We further examined local innate cell recruitment and CD8 T cell responses in the peritoneal cavity. FINDINGS: We observed that i.p. injected CAF09b associated with visceral fatty tissues and created a vaccine depot in the peritoneal cavity. This led to recruitment of BATF3-dependent conventional type I dendritic cells (cDC1) displaying a migratory cDC1 phenotype (CD11c+XCR1+CD103+). Gene ontology analysis further revealed similarities with visceral adipose tissue DCs. CAF09b injection i.p. led to early priming of CD8 T cells localized to the peritoneal cavity and this response was resistant to FTY720 treatment. INTERPRETATION: This study demonstrates that adjuvants can facilitate recruitment of cDC1s to the peritoneal cavity, a feature that may contribute to the effectiveness of i.p. administration on elicitation of CD8 T cell responses. Furthermore, we demonstrate that CAF09b-induced CD8 T cell responses require BATF3-dependent cDC1 cells. Understanding cDC1 and CD8 T cell dynamics via different immunization routes may aid in the design of more effective vaccine strategies. FUNDING: This work was primarily supported by the Danish Research Council (FTP fund no. 9041-00131b).

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Schmidt ST, Zimmermann J, Wørzner K, et al. Intraperitoneal administration of cationic liposomes containing a TLR3 agonist recruits type I conventional dendritic cells and primes a local CD8+ T cell response. Vaccine. 2025. PMID: 41313897. doi:10.1016/j.vaccine.2025.128029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。